Zobrazeno 1 - 10
of 112
pro vyhledávání: '"Christoph Jakob"'
Publikováno v:
PLoS ONE, Vol 16, Iss 11 (2021)
Increasing oncological treatment costs are a major global concern with the risk of entailing two-tiered health care. Among cost determining factors is the price of individual drugs. In recognition of the central role of this factor, we present a comp
Externí odkaz:
https://doaj.org/article/fb515dedab484f0ea4a3b0ad4f96f6bc
Autor:
Ulrich Güller, Rene Warschkow, Christoph Jakob Ackermann, Bruno M. Schmied, Thomas Cerny, Silvia Ess
Publikováno v:
Swiss Medical Weekly, Vol 148, Iss 0102 (2018)
Externí odkaz:
https://doaj.org/article/2f5e565fbd854f7baf75eff0dec7631d
Autor:
Ulrich Güller, Rene Warschkow, Christoph Jakob Ackermann, Bruno M. Schmied, Thomas Cerny, Silvia Ess
Publikováno v:
Swiss Medical Weekly, Vol 147, Iss 2930 (2017)
BACKGROUND In various countries, the association of lower hospital volume and higher mortality after oesophageal, gastric, pancreatic and rectal cancer resection has been clearly demonstrated. However, scientific evidence regarding the volume-outcom
Externí odkaz:
https://doaj.org/article/7f9928e0276c49c5b26a8a902867db15
Autor:
Clotilde Ferrandiz-Huertas, Sakthikumar Mathivanan, Christoph Jakob Wolf, Isabel Devesa, Antonio Ferrer-Montiel
Publikováno v:
Membranes, Vol 4, Iss 3, Pp 525-564 (2014)
ThermoTRP channels (thermoTRPs) define a subfamily of the transient receptor potential (TRP) channels that are activated by changes in the environmental temperature, from noxious cold to injurious heat. Acting as integrators of several stimuli and si
Externí odkaz:
https://doaj.org/article/7e0b5fa544104c59b7425095e6e3d8da
Autor:
Ackermann, Christoph Jakob, Reck, Martin, Paz-Ares, Luis, Barlesi, Fabrice, Califano, Raffaele
Publikováno v:
In Lung Cancer August 2019 134:245-253
Autor:
Rachamin, Yael1 (AUTHOR), Ackermann, Christoph Jakob2 (AUTHOR), Senn, Oliver1 (AUTHOR), Grischott, Thomas1 (AUTHOR) thomas.grischott@usz.ch
Publikováno v:
PLoS ONE. 11/15/2021, Vol. 16 Issue 11, p1-12. 12p.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Martin Reck, Christoph Jakob Ackermann, Adeel Khan, Raffaele Califano, Ana Ortega-Franco, Helen Adderley
Publikováno v:
Drugs. 80:1783-1797
The advent of PD-(L)1 and CTLA-4 immune check point inhibitors (CPIs) has dramatically changed the treatment landscape of advanced non-small-cell lung cancer (NSCLC). For up to a quarter of patients with advanced NSCLC, CPIs have the potential to ind
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::057556318084b42f07b1ba9d60e92957
https://doi.org/10.1007/s40265-020-01409-6
https://doi.org/10.1007/s40265-020-01409-6
Autor:
Shereen Rafee, Christoph Jakob Ackermann, Raffaele Califano, Fabio Gomes, Simon Ekman, Georgios Tsakonas
Publikováno v:
European Journal of Cancer. 125:1-11
In recent years, non-small cell lung cancer (NSCLC) entered in a new era of anticancer treatments with the success of checkpoint inhibitors (CPIs). These are now part of daily practice from locally advanced to metastatic NSCLC. However, the registrat
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c54f054839065fa3b75ae8136fccba3e
https://doi.org/10.1016/j.ejca.2019.11.010
https://doi.org/10.1016/j.ejca.2019.11.010
Publikováno v:
PLoS ONE
PLoS ONE, Vol 16, Iss 11 (2021)
PLoS ONE, Vol 16, Iss 11, p e0259936 (2021)
PLoS ONE, Vol 16, Iss 11 (2021)
PLoS ONE, Vol 16, Iss 11, p e0259936 (2021)
Increasing oncological treatment costs are a major global concern with the risk of entailing two-tiered health care. Among cost determining factors is the price of individual drugs. In recognition of the central role of this factor, we present a comp
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f978850d90117726197f47df13412622
https://doi.org/10.5167/uzh-209972
https://doi.org/10.5167/uzh-209972
